The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> July 30, 2015

Interview with the President & CEO: Applied Genetic Technologies Corporation (AGTC)

Washer, Sue
Sue Washer is President and CEO of Applied Genetic Technologies Corporation, or AGTC. Ms. Washer is an experienced entrepreneur with an impressive career over the past 32 years, with diverse experiences in the pharmaceutical/biologics industry, including extensive corporate startup experience, research and development expertise as well as significant community and industry association leadership. As founding CEO, Ms. Washer has led AGTC for 17 years, transforming it from a small academic spin-out to a leader in the field with five products in active development. Ms. Washer led AGTC’s successful IPO and secondary financing, raising more than $90 million from public investors; secured investments of more than $91 million from nationally recognized venture capitalists and granting agencies; negotiated and closed on a major collaboration with a top-five biotech company; negotiated numerous licensing deals with academic, governmental and commercial entities; led the company in efficiently completing critical milestones, including five INDs and three early-stage clinical trials; and recruited an experienced management team. Most recently, Ms. Washer led the negotiations with Biogen, resulting in a wide-ranging partnership deal with a $124 million upfront payment. Her experience as a group leader with Abbott’s Diagnostic Division helped hone her skills in bringing new products and technologies from the lab bench into the marketplace. Ms. Washer currently serves on the board of directors of BIO and ARM and is a member of the advisory board for the Florida High Tech Corridor Council. She has a degree in biochemistry from Michigan State University and an MBA from the University of Florida, where she was one of the first graduates from the Warrington College of Business Entrepreneurship program. Profile
TWST: Can you provide a simple brief overview of the company?

Ms. Washer: AGTC is a gene therapy company developing products in the orphan ophthalmology space. We work in areas where

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy